NZ323855A - Method and compositions for the synthesis of dioxolane nucleosides particularly the beta-configuration of the 1,3-dioxolane sugar rings - Google Patents

Method and compositions for the synthesis of dioxolane nucleosides particularly the beta-configuration of the 1,3-dioxolane sugar rings

Info

Publication number
NZ323855A
NZ323855A NZ323855A NZ32385596A NZ323855A NZ 323855 A NZ323855 A NZ 323855A NZ 323855 A NZ323855 A NZ 323855A NZ 32385596 A NZ32385596 A NZ 32385596A NZ 323855 A NZ323855 A NZ 323855A
Authority
NZ
New Zealand
Prior art keywords
dioxolane
beta
compositions
synthesis
configuration
Prior art date
Application number
NZ323855A
Other languages
English (en)
Inventor
Tarek Mansour
Alex Cimpoia
Krzysztof Bednarski
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of NZ323855A publication Critical patent/NZ323855A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ323855A 1995-12-14 1996-12-13 Method and compositions for the synthesis of dioxolane nucleosides particularly the beta-configuration of the 1,3-dioxolane sugar rings NZ323855A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9525606.1A GB9525606D0 (en) 1995-12-14 1995-12-14 Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
PCT/CA1996/000845 WO1997021706A1 (en) 1995-12-14 1996-12-13 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION

Publications (1)

Publication Number Publication Date
NZ323855A true NZ323855A (en) 1999-11-29

Family

ID=10785435

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ323855A NZ323855A (en) 1995-12-14 1996-12-13 Method and compositions for the synthesis of dioxolane nucleosides particularly the beta-configuration of the 1,3-dioxolane sugar rings

Country Status (27)

Country Link
US (4) US5922867A (en:Method)
EP (1) EP0970074B1 (en:Method)
JP (1) JP3229990B2 (en:Method)
KR (1) KR100406159B1 (en:Method)
CN (1) CN1080263C (en:Method)
AP (1) AP879A (en:Method)
AT (1) ATE214699T1 (en:Method)
AU (1) AU706328B2 (en:Method)
BR (1) BR9612351A (en:Method)
CA (1) CA2237730C (en:Method)
DE (1) DE69620042T2 (en:Method)
DK (1) DK0970074T3 (en:Method)
EA (1) EA000844B1 (en:Method)
ES (1) ES2172697T3 (en:Method)
GB (1) GB9525606D0 (en:Method)
HU (1) HU224076B1 (en:Method)
IL (3) IL124663A (en:Method)
IN (1) IN187349B (en:Method)
MX (1) MX9804701A (en:Method)
NO (1) NO309901B1 (en:Method)
NZ (1) NZ323855A (en:Method)
OA (1) OA11094A (en:Method)
PL (1) PL188447B1 (en:Method)
PT (1) PT970074E (en:Method)
TW (1) TW341574B (en:Method)
WO (1) WO1997021706A1 (en:Method)
ZA (1) ZA9610544B (en:Method)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0986375A2 (en) 1997-04-07 2000-03-22 Triangle Pharmaceuticals Inc. Use of mkc-442 in combination with other antiviral agents
WO2000009494A1 (en) 1998-08-12 2000-02-24 Triangle Pharmaceuticals, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
JP2002533470A (ja) * 1998-12-23 2002-10-08 シャイアー・バイオケム・インコーポレイテッド 抗ウイルス性ヌクレオシド類似体
EP1151133A1 (en) * 1999-02-11 2001-11-07 McGILL UNIVERSITY Stereoselective synthesis of nucleoside analogues
AU777869B2 (en) * 1999-09-24 2004-11-04 Shire Canada Inc. Method for the treatment or prevention of viral infection using nucleoside analogues
US6566365B1 (en) 1999-11-04 2003-05-20 Biochem Pharma Inc. Method for the treatment of Flaviviridea viral infection using nucleoside analogues
WO2001058920A2 (en) * 2000-02-10 2001-08-16 Mitsui Chemicals, Inc. Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
ATE360016T1 (de) 2000-02-11 2007-05-15 Shire Biochem Inc Ein stereoselektives verfahren zur herstellung von nukleosidanalogen
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
ES2253544T3 (es) 2001-03-01 2006-06-01 Gilead Sciences, Inc. Formas poliformicas y otras cristalinas de cis-ftc.
WO2003020222A2 (en) * 2001-09-04 2003-03-13 Merck & Co., Inc. PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
US6645972B2 (en) * 2001-11-02 2003-11-11 Shire Biochem Inc. Methods of treating leukemia
WO2003063771A2 (en) * 2001-12-14 2003-08-07 Pharmasset Ltd. N4-acylcytosine nucleosides for treatment of viral iinfections
CA2473736C (en) 2002-01-25 2011-10-11 Shire Biochem Inc. Process for producing dioxolane nucleoside analogues
AU2003294212B2 (en) 2002-08-06 2010-01-07 Pharmasset Inc. Processes for preparing 1,3-dioxolane nucleosides
JP4972284B2 (ja) 2002-10-15 2012-07-11 エクソンモービル・ケミカル・パテンツ・インク オレフィン重合のための複数触媒系及びそれらから生成されたポリマー
DE10335061B4 (de) 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
US7785839B2 (en) * 2004-02-03 2010-08-31 Emory University Methods to manufacture 1,3-dioxolane nucleosides
US7749531B2 (en) * 2005-06-08 2010-07-06 Indicator Systems International Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) * 2009-04-17 2012-01-25 中国石油化工股份有限公司 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
WO2018022263A1 (en) 2016-07-29 2018-02-01 Exxonmobil Chemical Patents Inc. Polymerization processes using high molecular weight polyhydric quenching agents
JP7337539B2 (ja) * 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
HUT64359A (en) * 1992-06-22 1993-12-28 Lilly Co Eli A stereoselective glycosyling procedure

Also Published As

Publication number Publication date
JP2000501714A (ja) 2000-02-15
HUP9901050A3 (en) 2001-05-28
HU224076B1 (hu) 2005-05-30
JP3229990B2 (ja) 2001-11-19
EP0970074A1 (en) 2000-01-12
GB9525606D0 (en) 1996-02-14
IN187349B (en:Method) 2002-03-30
EA000844B1 (ru) 2000-06-26
PT970074E (pt) 2002-09-30
PL188447B1 (pl) 2005-02-28
IL124663A (en) 2001-10-31
US20030060476A1 (en) 2003-03-27
DE69620042D1 (de) 2002-04-25
IL144155A0 (en) 2002-05-23
US5922867A (en) 1999-07-13
HUP9901050A2 (hu) 2001-04-28
NO982716D0 (no) 1998-06-12
CA2237730C (en) 2001-12-04
ATE214699T1 (de) 2002-04-15
CN1208414A (zh) 1999-02-17
ES2172697T3 (es) 2002-10-01
TW341574B (en) 1998-10-01
PL327443A1 (en) 1998-12-07
AU706328B2 (en) 1999-06-17
DE69620042T2 (de) 2002-10-17
NO309901B1 (no) 2001-04-17
CN1080263C (zh) 2002-03-06
WO1997021706A1 (en) 1997-06-19
CA2237730A1 (en) 1997-06-19
BR9612351A (pt) 1999-07-13
HK1017886A1 (en) 1999-12-03
AU1089397A (en) 1997-07-03
OA11094A (en) 2003-03-13
DK0970074T3 (da) 2002-07-15
MX9804701A (es) 1998-10-31
KR19990072141A (ko) 1999-09-27
EP0970074B1 (en) 2002-03-20
KR100406159B1 (ko) 2004-11-16
US20020058670A1 (en) 2002-05-16
ZA9610544B (en) 1997-07-29
NO982716L (no) 1998-06-12
IL124663A0 (en) 1998-12-06
EA199800555A1 (ru) 1999-02-25
AP879A (en) 2000-10-02
IL144155A (en) 2003-07-06
US6069250A (en) 2000-05-30
AP9801252A0 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
NZ323855A (en) Method and compositions for the synthesis of dioxolane nucleosides particularly the beta-configuration of the 1,3-dioxolane sugar rings
DK0513200T4 (da) Fremgangsmåde og sammensætninger til syntese af BCH-189 og beslægtede forbindelser
DK0594291T3 (da) Fremgangsmåder til fremstilling af 13-etherderivater af milbemyciner og mellemprodukter dertil
ZA911153B (en) Process for the preparation of oxetanones
LTIP1397A (en) Process for preparing deacylated 10-baccatine iii
IL101932A0 (en) Processes for the diastereoselective synthesis of oxathiolane,dioxolane and dithiolane derivatives,and oxathiolane and dioxolane derivatives for use therein
TW254946B (en:Method)
BG103133A (en) New erythromycins and method for their preparation
BG105547A (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
PL299415A1 (en) Method of obtaining nucleosides
IL87517A0 (en) Improvements in or relating to 2',2'-difluoronucleosides
EP1178051A4 (en) PROCESS FOR THE SELECTIVE PRODUCTION OF AN ANOMER DERIVED FROM 1-PHOSPHORYL SUGAR
WO1999064430A3 (en) Morphine-6-glucuronide synthesis
PL322503A1 (en) Method of obtaining nucleoside analoques
DK0640142T3 (da) Fremgangsmåde til fremtilling af avermectiner og kulturer hertil

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)